the shortage list question that gets asked weekly, answered properly
Genuinely asking, not being difficult.
Everyone in c/hplc repeats that 503A is important. I believe it, but I have never seen anyone show why, and when I search I get 11 threads of people agreeing with each other.
Is there a paper? Is there a measurement? Or is this one of those things that is true because it has been repeated since 2023?
I am not trying to be the "source?" guy. I would just like a source.
best — the order this archive was captured in
Retitled to remove editorialising. Put the evidence in the body.
What is the actual shortage list status right now?
Asked 17 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.
no pharmacy referral codes, naming is fine, recruiting is not
Did they tell you their API source or dodge the question?
the 503A/503B distinction is load-bearing, do not blur it
This is correct. The shortage list does expire and the rules change.
What is the actual shortage list status right now?
regulatory claims need a citation to the actual rule, not interpretation
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
The telehealth + compounding combo cost 503B plus 9% markup. Not cheap but covered by insurance depending on state.
Strongly agree. API source transparency matters.
The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.
- 1Asked 17 compounders about API source. One told me, one dodged, one said…12 comments in this branch · started by u/hydration_hank